The EBSP would enable Europeans to travel to the U.S. visa-free, provided that EU states grant access to biometric databases for traveler screening and IDV.

The Gene Synthesis Market has emerged as one of the most transformative segments within modern biotechnology, driven by rapid ...

ClearNote Health's enhanced Avantect Pancreatic Cancer Test features industry-leading detection sensitivity and specificity ...

Artificial Intelligence, Big data, Digital health, Global health, health news, Health technology, healthcare innovations, ...

Anemia in young adult women is rarely caused by a single factor. Instead, it reflects a layered interaction of nutritional deficiencies, physiological demands, chronic illnesses, genetic ...

For more than six decades, biomarker-based newborn screening has played a pivotal role in reducing infant mortality and ...

PROBLEM SOLVER AWARD FINALISTThe University of Queensland, Monash University and The University of SydneyACEMID: revolutionising early detection and the fight against melanoma ...

ClearNote Health, a company focused on improving early detection for some of the deadliest cancers, today announced the launch of its enhanced Avantect(R) Pancreatic Cancer Test, which delivers ...

Zifo, the leading global enabler of AI and data-driven enterprise informatics for science driven organizations and Maze Therapeutics Inc have partnered to solve the critical challenge of managing, ...

DUBAI – In a solid executive action that is in accordance with the UAE's National Strategy for Artificial Intelligence 2031, ...